2023
DOI: 10.1016/j.ymthe.2022.08.012
|View full text |Cite
|
Sign up to set email alerts
|

Transient secretion of VEGF protein from transplanted hiPSC-CMs enhances engraftment and improves rat heart function post MI

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
23
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 26 publications
(26 citation statements)
references
References 71 publications
0
23
0
Order By: Relevance
“…Ideal carriers should have the ability to deliver modRNA to specific cell types and permit significant transgene expression for a specified duration in order to attain a satisfactory therapeutic effect, while avoiding activation from host immune responses, and/or by exhibiting ‘stealth’ features for optimal safety. A common delivery agent of choice for many RNA studies has been lipid nanoparticles (such as commercial transfection reagents RNAiMAX and MessengerMAX), which effectively express exogenous genes with high efficiency [ 20 , 26 , 53 , 54 , 55 ]. However, cytotoxic side effects of lipid nanoparticle delivery systems are common.…”
Section: Resultsmentioning
confidence: 99%
“…Ideal carriers should have the ability to deliver modRNA to specific cell types and permit significant transgene expression for a specified duration in order to attain a satisfactory therapeutic effect, while avoiding activation from host immune responses, and/or by exhibiting ‘stealth’ features for optimal safety. A common delivery agent of choice for many RNA studies has been lipid nanoparticles (such as commercial transfection reagents RNAiMAX and MessengerMAX), which effectively express exogenous genes with high efficiency [ 20 , 26 , 53 , 54 , 55 ]. However, cytotoxic side effects of lipid nanoparticle delivery systems are common.…”
Section: Resultsmentioning
confidence: 99%
“… 34,35 In our previous studies, we incorporated m1ψ as a substitute for uridine‐5‐triphosphate in the mRNA molecules. These modifications have been demonstrated to enhance mRNA stability and improve protein secretion in various mRNA molecules 30,36–38 . Subsequently, we aimed to assess the efficiency of lipid‐mediated transfection of modRNA molecules encoding TGF‐β3, and IL‐10 (modGFP, modTGF‐β3, and modIL‐10) in hADSCs.…”
Section: Resultsmentioning
confidence: 99%
“…In recent studies, our team has documented the advantageous outcomes of a cell‐based mRNA delivery platform for enhancing therapeutic applications in limb ischemia, myocardial infarction, bone defects, corneal injury, and improvement of fat grafting. These studies have yielded promising results 30,36–38,50 . As an exploration in the field of scar‐less healing, we developed ADSCs dual , which can continuously express IL‐10 and TGF‐β3 using liposomal transient transfection of modRNA IL‐10 and TGF‐β3.…”
Section: Discussionmentioning
confidence: 99%
“…The potential impact of this study, however, extends beyond the consequences for embryonic development. Stem-cell-based therapies are considered to be one of the possible groundbreaking solutions for degenerative diseases such as type 1 diabetes, Parkinson’s, and heart failure, as they can be differentiated into virtually any somatic cell type [ 64 , 65 , 66 ]. Although great progress is being made in this field, differentiation protocols require further improvements to produce uniform populations of desired cells with high efficiencies.…”
Section: Discussionmentioning
confidence: 99%